World Molecular Imaging Society (WMIS) is an international organization dedicated to developing and promoting multimodal molecular imaging research worldwide.
Hyperpolarized (129)Xe-MRI was used to evaluate the role of the MAPK pathway in wound healing in a murine model of emphysema.
Check out the full study by Kimura et al. here: rdcu.be/e4xR4
Pafolacianine (Cytalux®), an FDA-approved intraoperative imaging agent, was evaluated for the fluorescence-guided surgery of head and neck squamous cell carcinoma.
Read more on this preclinical investigation by Mani et al. here: rdcu.be/e4xuz
Physics, biology, chemistry, and medicine: WMIC is where imaging worlds collide. Whether you are a trainee or tenured, your research deserves a global audience.
⏰ 6 weeks until abstract deadline!
Submit here: wmis.org/wmic-2026/abstract-…#WMIC2026#SLC#molecularImaging
Gan et al. have performed a first-in-human clinical trial of (89)Zr-Bintrafusp Alfa, a bifunctional fusion protein, in non-small cell lung cancer patients with PD-L1-expressing tumors.
Check out the full article! rdcu.be/e4xfo
A molecular imaging showdown! In this study, Zheng et al. set out to compare the diagnostic performances of (68)Ga-FAPI-PET, (18)FDG-PET, enterography, and intestinal ultrasound in patients with Crohn’s disease.
Read more here! rdcu.be/e4wEn
#MIBArticleHighlight Peng et al. have developed a new approach to antiplatelet therapy via local infusion of ticagrelor-loaded PLGA magnetic microspheres (PFTm). Upon infusion of PFTm, local thrombosis was inhibited. Read more here! rdcu.be/eEVxN
#MIBArticleHighlight Park et al. report the simultaneous use of dopamine transporter and amyloid tracers in Parkinson’s disease and Alzheimer’s disease mouse models, demonstrating the potential of dual-target PET imaging. Access the full article here! rdcu.be/eEVwU
#MIBArticleHighlight In the latest installment of #MIBGuides, Simo et al. describe step-by-step protocols for the production of trastuzumab with zirconium-89 and copper-64. Click here for the full Guide! rdcu.be/eEVvJ
#MIBArticleHighlight In this Phase 2 clinical trial follow-up, Warmerdam et al. demonstrated that patients whose surgical approach was less invasive and more effective based on NIRF showed favorable long-term outcomes. Check out the full article! rdcu.be/eEVst
As new therapies become more targeted, we need imaging tools that can guide decisions throughout the treatment journey.
Molecular imaging helps identify the right patients, monitor their response, and adapt care over time.
Share your research at WMIS wmis.org/membership/
🌟 Upcoming WMIS Webinar 🌟
Join us on Sept 8 at 11 AM ET for a live discussion with Teri Odom, PhD: “Nanoparticle Shape Effects on Nano-Bio Interactions”
đź“… Sept 8 | 11 AM ET
đź”— Register here: ow.ly/8nSW50WQxwj#Nanomedicine#Nanoparticles#CancerResearch
LAST DAY TO SUBMIT - TODAY, AUGUST 29, 2025
New Approach Methodologies (NAMs) in Preclinical Imaging Special Call for Posters
We are seeking forward-thinking poster contributions that demonstrate integration of NAMs in preclinical imaging
👉 Details: ow.ly/vjjo50WOcQa